Woman Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
The study will be an open controlled pilot study of 6 patients with early-onset severe preeclampsia. Patients will receive Atenativ in addition to conventional therapy The patients will be followed up within the study until three days after delivery. Laboratory analyses and uterine and umbiliacal blood flow will be determined.
Inclusion criteria
- Antithrombin III deficiency